Bayer Moves Closer to Winning Merck Unit

Your next video will start in

Recommended Videos

  • Info

  • Comments


May 1 (Bloomberg) –- Bloomberg’s Hans Nichols reports on Bayer moving closer to winning Merck’s consumer business because it’s leading rival, Reckitt Benckiser, walked away from the deal. He speaks to Anna Edwards and Mark Barton on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

International correspondent hans nichols has the latest from berlin.

Why did they walk away from this then?

They got into a bidding war.

The asset simply became too expensive and as the ceo explained, they have very strict metrics.

This quote was sent out.

We are a very highly disciplined acquirer with strict return metrics that we will not break.

It is the ceo.

What they have offered is to do cash swap assets for animal health pharmaceuticals and oncology businesses.

Initially when they put it up they were talking about it being worth $12 billion and it has creeped up to $14 billion.

This is the consumer-led business.

Coppertone sunscreen, i know in england it is not used very much but it is a big business and we have seen lots of m and ta, lots of swaps in part because they are so cash-rich.

The challenge, how and where did they spend and invest in the future, and just what they do to have a unified business that does not get to extraneous and is more focused.

It looks that it seems to be going through between bayer and merck.

This just gives us a little more clarity.

I know some ladies in this

This text has been automatically generated. It may not be 100% accurate.


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change